Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment

Objective: to study the breast cancer phenotype (ER/PR, FOXA1, HER2, Ki67) and the dynamics of changes in these markers in the tumour before and after neoadjuvant chemotherapy (NAT), compare them with metastases in the regional lymph nodes (LN). Materials and methods. The subject of the study was a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2018-07-01
Colecção:Медицинский совет
Assuntos:
breast cancer
neoadjuvant chemotherapy
tumor immunophenotype
Acesso em linha:https://www.med-sovet.pro/jour/article/view/2547
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados